Award
Delivery Order #SPE2DR26F3XVB
Delivery Order for Hydroxyzine HCl Tablets under AmerisourceBergen Pharmaceutical IDV
Buyer
Defense Logistics Agency
Award Amount
$6.71
Ceiling
$6.71
Awarded
March 11, 2026
Period of Performance
Mar 11, 2026 – Mar 12, 2026
Identifier
SPE2DR26F3XVB
NAICS
424210
This award represents a delivery order contract procured under an existing Indefinite Delivery Vehicle (IDV) held by AmerisourceBergen Drug Corporation, a leading pharmaceutical distribution company. The contract specifies the provision of Hydroxyzine HCl 25 mg tablets, a medication essential for various therapeutic uses, to fulfill agency pharmaceutical needs. The delivery order is a short-term, specific purchase within the broader multi-year IDV that AmerisourceBergen holds for supplying pharmaceutical products, underscoring the company's critical role in maintaining a reliable medication supply chain for federal health programs. The scope includes the timely delivery of the specified medication to the designated location in Conshohocken, Pennsylvania. This delivery order was awarded as a direct follow-on to the parent IDV contract, leveraging an existing competitive contract vehicle to ensure efficient procurement and continuity of service. The contract performance period is notably brief, reflecting its nature as a discrete delivery within the long-term pharmaceutical supply arrangement. Overall, this contract segment highlights the ongoing collaboration between the government and AmerisourceBergen to support healthcare logistics and public health through dependable pharmaceutical distribution.
Description
4571119083!HYDROXYZINE HCL 25 MG TABLET 100S